Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells

Circulation Research

Volumn 84, Issue 5, 1999, Pages 505-515

  Touyz, R M ^a   El Mabrouk, M ^b   He, G ^b   Wu, X H ^b   Schiffrin, E L ^b  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b NONE

Author keywords

Hypertension; PD98059; pH(i); Resistance vessel; Ca2+ (i)

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN; CALCIUM; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; ENZYME ASSAY; HYPERTENSION; IMMUNOBLOTTING; MALE; MESENTERIC ARTERY; MICROPHOTOGRAPHY; NONHUMAN; PH; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SYSTOLIC BLOOD PRESSURE; VASCULAR SMOOTH MUSCLE;

EID: 0033583265     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.5.505     Document Type: Article

References (48)

1. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982;62:347-504.
2. Schiffrin EL. Intracellular signal transduction for vasoactive peptides in hypertension. Can J Physiol Pharmacol. 1994;72:954-962.
3. Touyz RM, Deng L-Y, Schiffrin EL. Differential effects of vasopressin and endothelin-I on vascular contractile and calcium responses in pressurized small arteries from spontaneously hypertensive rats. J Hypertens. 1996;14:983-991.
4. Resink TJ, Scott-Burden T, Baur U, Bürgin M, Buhler FR. Enhanced responsiveness to angiotensin II in vascular smooth muscle cells from spontaneously hypertensive rats is not associated with alterations in protein kinase C. Hypertension. 1989;14:293-303.
5. Touyz RM, Tolloczco B, Schiffrin EL. Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II, but not to endothelin-1. Hypertension. 1994;12:663-673.
6. Chatziantoniou C, Daniels FH, Arendshorst WJ. Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Am J Physiol. 1990;259:F372-F382.
7. Berecek KH, Scwertschlag U, Gross F. Alterations in renal vascular resistance and reactivity in spontaneous hypertension of rats. Am J Physiol. 1980;238:H287-H293.
8. Couture R, Regoli D. Vascular reactivity to angiotensin and noradrenaline in spontaneously and renal hypertensive rats. Clin Exp Hypertens. 1980; 2:45-63.
9. Couture R, Regoli D. Vascular reactivity to angiotensin and noradrenaline in rats maintained on a sodium free diet or made hypertensive with desoxycorticosterone acetate and salt (DOCA/salt). Clin Exp Hypertens. 1980;2:25-43.
10. Heagerty AM, Ollerenshaw JD, Swales JD. Abnormal vascular phosphoinositide hydrolysis in the spontaneously hypertensive rat. Br J Pharmacol. 1986;89:803-807.
11. Rosskopf D, Dusing R, Siffert W. Membrane sodium-proton exchange and primary hypertension. Hypertension. 1993;21:607-617.
12. Rembold CM. Regulation of contraction and relaxation in arterial smooth muscle. Hypertension. 1992;20:129-137.
13. Sauro MD, Sudakov R, Burns S. In vivo effects of angiotensin II on vascular smooth muscle contraction and blood pressure are mediated through a protein tyrosine-kinase-dependent mechanism. J Pharmacol Exp Ther. 1996;277:1744-1750.
14. Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Circ Res. 1997;80:607-616.
15. Butcher RD, Schollman C, Marme D. Angiotensin II mediates intracellular signalling in vascular smooth muscle cells by activation of tyrosine-specific protein kinases and c-raf-1. Biochem Biophys Res Commun. 1993;196:1280-1287.
16. Touyz RM, Schiffrin EL. Angiotensin II regulates vascular smooth muscle cell pH, contraction and growth via tyrosine-kinase dependent signaling pathways. Hypertension. 1997;30(part 1):222-229.
17. Wang JYJ, McWhirter JR. Tyrosine-kinase-dependent signaling pathways. Trends Cardiovasc Med. 1994;4:264-270.
18. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997;9:180-186.
19. Force T, Bonventre JV. Growth factors and mitogen-activated protein kinases. Hypertension. 1998;31(part 2):152-161.
20. Jin N, Siddiqui RA, English D, Rhoades RA. Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle. Am J Physiol. 1996;271:H1348-H1355.
21. Touyz RM, Schiffrin EL. Tyrosine kinase signaling pathways modulate angiotensin II-induced calcium transients in vascular smooth muscle cells. Hypertension. 1996;27:1097-1103.
22. Epstein AM, Throckmorton D, Brophy CM. Mitogen-activated protein kinase activation: an alternate signaling pathway for sustained vascular smooth muscle contraction. J Vasc Surg. 1997;26:327-332.
23. Watts SW. Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: use of the mitogen-activated protein kinase kinase inhibitor PD098059. J Pharmacol Exp Ther. 1996;279: 1541-1550.
24. Dudley DT, Pang L, Decker JS, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A. 1995;92:7686-7689.
25. Touyz RM, Schiffrin EL. Role of calcium influx and intracellular calcium stores in angiotensin II-mediated calcium hyperresponsiveness in smooth muscle from spontaneously hypertensive rats. J Hypertens. 1997;15: 1431-1439.
26. Li X, Tsai P, Wieder E, Kribben A, Putten VV, Schrier RW, Nemenoff RA. Vascular smooth muscle cells grown on Matrigel: a model of the contractile phenotype with decreased activation of mitogen-activated protein kinase. J Biol Chem. 1994;269:19653-19658.
27. Kahn AM, Bishara M, Cragoe FJ Jr, Allen-JC, Seidel CL, Navran SS, O'Neil RG, McCarty NA, Shelat H. Effects of serotonin on intracellular pH and contraction in vascular smooth muscle. Circ Res. 1992;71: 1294-1304.
28. Bodin P, Travo C, Stoclet JC, Travo P. High sensitivity of hypertensive aortic myocytes to norepinephrine and angiotensin. Am J Physiol. 1993; 264:C441-C445.
29. Wray S. Smooth muscle intracellular pH: measurement, regulation and function. Am J Physiol. 1988;254:C213-C225.
30. 2+ indicators with greatly improved fluorescent properties. J Biol Chem. 1985; 260:3440-3450.
31. Thomas JA, Buchbaum RN, Zimniak A, Racker E. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry. 1979;18:2210-2218.
32. Schiffrin EL, Thome FS, Genest J. Vascular angiotensin II receptors in SHR. Hypertension. 1984;6:682-688.
33. Austin C, Duly K, Eisner D, Wray S. Simultaneous measurement of intracellular pH, calcium and tension in rat mesenteric vessels: effects of extracellular pH. Biochem Biophys Res Commun. 1996;222:537-540.
34. Berridge MJ. Spatial and temporal signalling by calcium. Curr Opin Cell Biol. 1994;6:267-274.
35. Alexander RW, Brock TA, Gimbrone MA Jr, Rittenhouse SE. Angiotensin increases inositol trisphosphate and calcium in vascular smooth muscle. Hypertension. 1985;7:447-451.
36. 2-terminal kinase activities are continuously and differentially increased in aorta of hypertensive rats. Biochem Biophys Res Commun. 1997;236:199-204.
37. Pang L, Sawada T, Decker SJ, Saltiel AR. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem. 1995;270:13585-13588.
38. 2+-dependent mitogen-activated protein kinase activation in spontaneously hypertensive rat vascular smooth muscle cells. J Biol Chem. 1997;272:16018-16022.
39. Adam LP, Franklin MJ, Raff GJ, Hathaway DR. Activation of mitogen-activated protein kinase in porcine carotid arteries. Circ Res. 1995;76: 183-190.
40. Whitney G, Throckmorton D, Isales C, Takuwa Y, Yeh J, Rasmussen H, Brophy C. Kinase activation and smooth muscle contraction in the presence and absence of calcium. J Vasc Surg. 1995;22:37-44.
41. Chao TSO, Byron KL, Lee KM, Villereal M, Rosner MR. Activation of MAP kinases by calcium-dependent and calcium-independent pathways. J Biol Chem. 1992;267:19876-19883.
42. Eguchi S, Matsumoto T, Motley ED, Utsunomiya H, Inagami T. Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells. J Biol Chem. 1996;271:14169-14175.
43. Goutsouliak V, Rabkin SW. Angiotensin II-induced inositol phosphate generation is mediated through tyrosine kinase pathways in cardiomyocytes. Cell Signal. 1997;9:505-512.
44. Wïjetunge S, Aalkjaer C, Schachter M, Hughes AD. Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun. 1992;189:1620-1623.
45. Hermsmeyer K, Sturek M, Marvin W, Mason R, Puga A. Vascular muscle calcium channel modulation in hypertension. J Cardiovasc Pharmacol. 1989;14(suppl 6):545-548.
46. Orlov S, Resink TJ, Bernhardt J, Ferracin F, Buhler FR. Vascular smooth muscle cell calcium fluxes regulation by angiotensin II and lipoproteins. Hypertension. 1993;21:195-203.
47. + exchange kinetics and its activation by angiotensin II. Am J Physiol. 1988;254:C751-C758.
48. + exchanger in human platelets. Different effect of phorbol ester and vasopressin. J Biol Chem. 1996;271:16494-16499.